Global Surgical Tourniquet Market Outlook to 2028

Global Surgical Tourniquet Market Overview

The global surgical tourniquet market reached a valuation of USD 475.13 million in 2023, driven by the increasing prevalence of orthopedic surgeries, trauma cases, and the adoption of advanced surgical technologies. The market's growth is fueled by rising healthcare expenditures, an aging population leading to more surgical procedures, and innovations in tourniquet systems, including the development of smart and disposable tourniquets. This market is essential in providing critical tools for surgeries where bloodless operating fields are necessary.

Major players in the global surgical tourniquet market include Zimmer Biomet, Stryker Corporation, Ulrich Medical, Delfi Medical, and Hammarplast Medical. These companies dominate the market through extensive product portfolios, strong R&D capabilities, and strategic acquisitions. Their global distribution networks and focus on continuous product innovation have solidified their leadership positions in the surgical tourniquet industry.

In 2024, Stryker Corporation expanded its surgical tourniquet product line by introducing a new electronic tourniquet system designed for complex orthopedic surgeries. This system features real-time pressure monitoring and automatic adjustments, enhancing patient safety during surgeries. Additionally, Delfi Medical launched a lightweight, portable tourniquet system aimed at outpatient and ambulatory surgical centers, reflecting the growing trend towards minimally invasive surgeries.

North America dominates the global surgical tourniquet market, driven by high demand for surgical procedures and advanced healthcare infrastructure. The region's regulatory environment, particularly the U.S. FDAs updated guidelines on surgical tourniquet safety, has also propelled market growth. Europe follows closely, with strong demand from countries like Germany and the UK, where healthcare systems are increasingly adopting disposable tourniquet systems.

Global Surgical Tourniquet Market Segmentation

The Global Surgical Tourniquet Market can be segmented based on Product Type, Application, and Region.

By Product Type: The market is segmented by product type into pneumatic tourniquets, manual tourniquets, and electronic tourniquets. In 2023, pneumatic tourniquets held the dominant market share due to their widespread use in orthopedic surgeries. The preference for pneumatic tourniquets stems from their ability to maintain consistent pressure, reducing the risk of complications.

By Application: The market is further segmented by application into orthopedic surgeries, trauma surgeries, and emergency care. In 2023, the orthopedic surgeries segment accounted for the largest market share due to the high number of knee and hip replacement procedures globally. The demand for tourniquets in orthopedic surgeries is driven by the need to create a bloodless surgical field, which is essential for the precision and success of these procedures.

By Region: Geographically, the market is segmented into North America, Europe, Asia- Pacific, Latin America, and MEA. In 2023, North America dominated the market, driven by a high concentration of key players, advanced healthcare infrastructure, and strong demand for surgical procedures. The regions regulatory environment and significant R&D investments have also contributed to its leadership position.

Global Surgical Tourniquet Market Competitive Landscape

Company

Headquarters

Establishment Year

Zimmer Biomet

Warsaw, Indiana, USA

1927

Stryker Corporation

Kalamazoo, Michigan, USA

1941

Ulrich Medical

Ulm, Germany

1912

Delfi Medical

Vancouver, Canada

1988

Hammarplast Medical

Lidkping, Sweden

1967

Zimmer Biomet (2024): Zimmer Biomet launched its latest disposable tourniquet system in 2024, designed for single-use applications to reduce cross-contamination risks in surgical settings. This new product has gained traction in hospitals across Europe and North America, where infection control is a top priority. The companys focus on innovation and safety enhancements has further strengthened its position in the global market.

Hammarplast Medical: Hammarplast Medical launched the Tourniquet 800in2021, a double-channel pneumatic tourniquet featuring a touch screen interface that eliminates physical buttons, thereby enhancing safety. This device is equipped with a NiM H battery backup, ensuring reliable operation even during power outages, which is critical in surgical environments.

Global Surgical Tourniquet Market Analysis

Market Growth Drivers:

Rising Number of Orthopedic Surgeries: The increasing number of orthopedic surgeries globally is a significant growth driver for the surgical tourniquet market. The demand for tourniquets is particularly high in knee and hip replacement surgeries, where maintaining a bloodless field is crucial. In 2023, over 2.2 million knee replacement surgeries were performed worldwide, with the United States and Europe leading in procedure volumes. This trend is expected to continue, driven by the aging population and the prevalence of musculoskeletal disorders.

Adoption of Advanced Tourniquet Systems: The adoption of advanced tourniquet systems, including smart and electronic tourniquets, is driving market growth. These systems offer features such as real-time pressure monitoring and automatic adjustments, enhancing patient safety during surgeries. In 2024, the adoption of smart tourniquet systems increased by 15% in North America, reflecting the growing demand for advanced surgical tools that improve outcomes and reduce complications.

Increasing Awareness and Training: There is a growing emphasis on proper training and awareness in surgical tourniquets, particularly in developing regions. In 2024, WHO launched a global training program aimed at educating healthcare professionals on the safe and effective use of tourniquets. This initiative is expected to reduce the incidence of tourniquet-related complications and improve surgical outcomes in regions where training has been limited.

Global Surgical Tourniquet Market Challenges:

High Cost of Advanced Systems: The high cost of advanced tourniquet systems remains a significant challenge for the market. In 2024, the average cost of an electronic tourniquet system was recorded at USD 12,000, making it less accessible for smaller hospitals, particularly in developing regions. This cost barrier limits the adoption of these systems, affecting market growth in areas with limited healthcare budgets.

Regulatory Compliance: Navigating the complex regulatory landscape for medical devices is another challenge for the surgical tourniquet market. In 2023, the European Union implemented new Medical Device Regulation (MDR) standards, increasing the cost and time required to bring new tourniquet products to market. Smaller manufacturers, in particular, face difficulties in meeting these stringent regulatory requirements, which can hinder innovation and market entry.

Global Surgical Tourniquet Market Government Initiatives:

Indias National Medical Devices Policy (2024): The Government of India launched the National Medical Devices Policy in 2024, aimed at promoting the domestic manufacturing of medical devices, including surgical tourniquets. The policy provides financial incentives and tax breaks to local manufacturers, encouraging them to invest in the production of cost-effective tourniquets. This initiative is expected to boost the growth of the surgical tourniquet market in India by reducing dependency on imports.

European Unions MDR Implementation (2023): The implementation of the Medical Device Regulation (MDR) in 2023 by the European Union has had a significant impact on the surgical tourniquet market. The MDR requires stricter testing, certification, and post-market surveillance of medical devices, including tourniquets. This regulation has pushed manufacturers to innovate and improve the safety and efficacy of their products, fostering a more competitive and high-quality market environment.

Global Surgical Tourniquet Market Future Outlook

Future Market Trends:

Expansion of Smart Tourniquet Systems: By 2028, the global surgical tourniquet market is expected to see significant growth, driven by the widespread adoption of smart tourniquet systems. These systems, equipped with advanced sensors and real-time data analytics, will become standard in operating rooms worldwide. The integration of artificial intelligence (AI) and machine learning (ML) into these systems will enable more precise pressure control and personalized settings for each patient, reducing the risk of complications and improving surgical outcomes.

Increased Use of Disposable Tourniquets: The trend towards single-use medical devices will continue to grow, with disposable tourniquets becoming the preferred choice in most healthcare settings by 2028. This shift will be driven by stringent infection control protocols and the need to reduce hospital-acquired infections (HAIs). As a result, the disposable tourniquet segment is projected to see robust growth, particularly in developed markets such as North America and Europe, where healthcare regulations are increasingly favoring single-use products.
Please Note: It will take 5-7 business days to complete the report upon order confirmation